Back to Search
Prempro
by Wyeth Pharmaceuticals LlcMHTTablet (Oral)
Actively PrescribedReference Drug

Estrogen

Non-Bioidentical

Estrogens, Conjugated

0.625Mg

Progestin

Non-Bioidentical

Medroxyprogesterone Acetate

5Mg

Estrogen Dose Type

Medium

Progestin Dose Type

High

Regimen

Cyclic sequential (28 Day)

Approval Date

1/9/1998

Inactive Ingredients
Lactose monohydrateLactoseTitanium dioxideCalcium phosphate tribasicHydroxypropyl celluloseMicrocrystalline cellulosePowdered celluloseHypromelloseMagnesium stearatePolyethylene glycolSucroseFD&C Blue No. 2FD&C Red No. 40Calcium sulfateCarnauba waxCelluloseGlyceryl monooleateMethylcellulosePharmaceutical glazePovidoneBlack iron oxide

Contains common allergens

Alternative Doses Available
This drug is available in different dose strengths. Currently viewing: Medium dose

Low Estrogen Dose

PremproEstrogens, Conjugated 0.3Mg / Medroxyprogesterone Acetate 1.5Mg
PremproEstrogens, Conjugated 0.45Mg / Medroxyprogesterone Acetate 1.5Mg

Medium Estrogen Dose

PremproEstrogens, Conjugated 0.625Mg / Medroxyprogesterone Acetate 2.5Mg
Premphase 14/14Estrogens, Conjugated 0.625Mg,0.625Mg / Medroxyprogesterone Acetate NA,5Mg

High Progesterone Dose

Estrogens, Conjugated 0.625Mg,0.625Mg / Medroxyprogesterone Acetate NA,5Mg

No active alternative brands with the same formulation

Have clinical questions about Prempro?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy